In this episode we talk to Mark Lowdell, a professor of cell and tissue therapy at UCL. Mark is also co-founder and owner of INmuneBio and Autolomous, two business at the forefront of the burgeoning field of immuno-oncology, an exciting and hugely important area of medicine.
Today we ask Mark about his leadership journey. We discuss how he fell into leadership, and how he is helping to establish new practices that are redefining the relationships between academic research and commercial big pharma.
